Standard Chemical & Pharmaceutical Co Ltd (1720)

Currency in TWD
63.50
-0.30(-0.47%)
Closed·
High dividend Yield
1720 is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
63.2063.90
52 wk Range
53.5066.60
Key Statistics
Bid/Ask
38.70 / 38.75
Prev. Close
60.1
Open
63.5
Day's Range
63.2-63.9
52 wk Range
53.5-66.6
Volume
229.37K
Average Volume (3m)
387.23K
1-Year Change
12.1908%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1720 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
73.00
Upside
+14.96%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield
Show more

Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicines, cosmetics, beverages, general instruments, and medical devices. It also provides western pharmaceuticals for cardiovascular, metabolic, genitourinary and sex steroids, respiratory, musculoskeletal, digestive, nervous, and circulatory systems; anti-infectives and topical medications; and cancer and cancer antiemetic. In addition, the company offers health food products. Further, it is involved in the manufacture and sale of active pharmaceutical ingredients, as well as veterinary drugs; and sales of medical devices and infant milk powder. It also exports its products. The company was incorporated in 1967 and is headquartered in Tainan City, Taiwan.

Compare 1720 to Peers and Sector

Metrics to compare
1720
Peers
Sector
Relationship
P/E Ratio
12.3x23.8x−0.4x
PEG Ratio
2.332.060.00
Price/Book
1.9x1.9x2.6x
Price / LTM Sales
1.6x1.5x3.2x
Upside (Analyst Target)
14.4%31.4%50.6%
Fair Value Upside
Unlock29.1%6.6%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 73.00
(+14.96% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.18%
Dividend Yield
4.66%
Industry Median 2.31%
Annualised payout
2.80
Paid annually
5-Years Growth
+2.13%
Growth Streak

Earnings

Latest Release
25/02/2026
EPS / Forecast
1.27 / 1.37
Revenue / Forecast
1.79B / 1.85B
EPS Revisions
Last 90 days

SCPC (1720) Income Statement & Profits

People Also Watch

1,060.0
8613
-1.67%
128.50
3010
+1.58%
426.0
8897
0.00%
263.00
3587
+3.34%
24.95
2010
-0.60%

FAQ

What Is the SCPC (1720) Share Price Today?

The SCPC stock price today is 63.50 TWD.

What Stock Exchange Does SCPC (1720) Trade On?

SCPC is listed and trades on the Taiwan Stock Exchange.

What Is the Ticker (Stock Symbol) for SCPC?

The stock symbol (also called a 'ticker') for SCPC is "1720."

Does SCPC Pay Dividends? What’s The Current 1720 Dividend Yield?

Yes, 1720 Pays Dividends to its Shareholders. The current SCPC dividend yield is 4.44%.

What Is the Current SCPC Market Cap?

As of today, SCPC market cap is 11.28B TWD.

What Is SCPC's (1720) Earnings Per Share (TTM)?

The SCPC EPS is currently 5.18 (Trailing Twelve Months).

When Is the Next SCPC Earnings Date?

SCPC's next earnings report will be released on 13/05/2026.

Is 1720 a Buy or Sell From a Technical Analyst Perspective?

Based on today's SCPC moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has SCPC Stock Split?

SCPC has split 9 times. (See the 1720 stock split history page for full effective split date and price information.)

What is the current trading status of SCPC (1720)?

As of 10/04/2026, SCPC (1720) is trading at a price of 63.50 TWD, with a previous close of 60.10 TWD. The stock has fluctuated within a day range of 63.20 TWD to 63.90 TWD, while its 52-week range spans from 53.50 TWD to 66.60 TWD.

What Is SCPC (1720) Price Target According to Analysts?

The average 12-month price target for SCPC is 73.00 TWD, with a high estimate of 73 TWD and a low estimate of 73 TWD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +14.96% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.